Does AXITINIB Cause Renal cell carcinoma? 154 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Renal cell carcinoma have been filed in association with AXITINIB (INLYTA). This represents 1.0% of all adverse event reports for AXITINIB.
154
Reports of Renal cell carcinoma with AXITINIB
1.0%
of all AXITINIB reports
63
Deaths
47
Hospitalizations
How Dangerous Is Renal cell carcinoma From AXITINIB?
Of the 154 reports, 63 (40.9%) resulted in death, 47 (30.5%) required hospitalization, and 5 (3.2%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
TACROLIMUS (98)
Which AXITINIB Alternatives Have Lower Renal cell carcinoma Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE